Literature Collection

Magnifying Glass
Collection Insights

12K+

References

11K+

Articles

1600+

Grey Literature

4800+

Opioids & SU

The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Enter Search Term(s)
Year
Sort by
Order
Show
12769 Results
6821
Long-term effectiveness of disseminating quality improvement for depression in primary care
Type: Journal Article
Authors: C. D. Sherbourne, K. B. Wells, N. Duan, J. Miranda, J. Unutzer, L. Jaycox, M. Schoenbaum, L. S. Meredith, L. V. Rubenstein
Year: 2001
Topic(s):
Financing & Sustainability See topic collection
6822
Long-term effects of a collaborative care intervention in persistently depressed primary care patients
Type: Journal Article
Authors: W. Katon, J. Russo, M. Von Korff, E. Lin, G. Simon, T. Bush, E. Ludman, E. Walker
Year: 2002
Topic(s):
Financing & Sustainability See topic collection
6824
Long-term effects on medical costs of improving depression outcomes in patients with depression and diabetes
Type: Journal Article
Authors: W. J. Katon, J. E. Russo, M. Von Korff, E. H. Lin, E. Ludman, P. S. Ciechanowski
Year: 2008
Abstract: Abstract. OBJECTIVE: The purpose of this study was to examine the 5-year effects on total health care costs of the Pathways depression intervention program for patients with diabetes and comorbid depression compared with usual primary care. RESEARCH DESIGN AND METHODS: The Pathways Study was conducted in nine primary care practices of a large HMO and enrolled 329 patients with diabetes and comorbid major depression. The current study analyzed the differences in long-term medical costs between intervention and usual care patients. Participants were randomly assigned to a nurse depression intervention (n = 164) or to usual primary care (n = 165). The intervention included education about depression, behavioral activation, and a choice of either starting with support of antidepressant medication treatment by the primary care doctor or problem-solving therapy in primary care. Interventions were provided for up to 12 months, and the main outcome measures are health costs over a 5-year period. RESULTS: Patients in the intervention arm of the study had improved depression outcomes and trends for reduced 5-year mean total medical costs of -$3,907 (95% CI -$15,454 less to $7,640 more) compared with usual care patients. A sensitivity analysis found that these cost differences were largely explained by the patients with depression and the most severe medical comorbidity. CONCLUSIONS: The Pathways depression collaborative care program improved depression outcomes compared with usual care with no evidence of greater long-term costs and with trends for reduced costs among the more severely medically ill patients with diabetes.
Topic(s):
Financing & Sustainability See topic collection
6826
Long-Term Follow-Up of Medication-Assisted Treatment for Addiction to Pain Relievers Yields "Cause for Optimism"
Type: Web Resource
Authors: Eric Sarlin
Year: 2015
Publication Place: Bethesda, MD
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

6827
Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial.
Type: Journal Article
Authors: Yih-Ing Hser, Elizabeth Evans, David Huang, Robert Weiss, Andrew Saxon, Kathleen M. Carroll, George Woody, David Liu, Paul Wakim, Abigail G. Matthews, Mary Hatch-Maillette, Eve Jelstrom, Katharina Wiest, Paul McLaughlin, Walter Ling
Year: 2016
Topic(s):
Opioids & Substance Use See topic collection
6830
Long-Term Prospects for Telemedicine in Opioid Use Disorder (OUD) Treatment: Results from a Longitudinal Survey of OUD Clinicians
Type: Journal Article
Authors: H. A. Huskamp, L. Riedel, I. Campa, A. B. Busch, S. Rose, A. Mehrotra, L. Uscher-Pines
Year: 2023
Topic(s):
Opioids & Substance Use See topic collection
,
HIT & Telehealth See topic collection
,
Education & Workforce See topic collection
6831
Long-Term Retention in an Outpatient Behavioral Health Clinic With Buprenorphine
Type: Journal Article
Authors: C. Montalvo, B. Stankiewicz, A. Brochier, D. C. Henderson, C. P. C. Borba
Year: 2019
Publication Place: England
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
6832
Long-term retention in Office Based Opioid Treatment with buprenorphine
Type: Journal Article
Authors: Z. M. Weinstein, H. W. Kim, D. M. Cheng, E. Quinn, D. Hui, C. T. LaBelle, M. L. Drainoni, S. S. Bachman, J. H. Samet
Year: 2017
Publication Place: United States
Topic(s):
Opioids & Substance Use See topic collection
6833
Long-term treatment retention in West Virginia's comprehensive opioid addiction treatment (COAT) program
Type: Journal Article
Authors: Laura R. Lander, Wanhong Zheng, Jeremy D. Hustead, James J. Mahoney III, James H. Berry, Patrick Marshalek, Erin L. Winstanley
Year: 2020
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
6834
Long-term treatment with buprenorphine/naloxone in primary care: Results at 2-5 years.
Type: Journal Article
Authors: David A. Fiellin, Brent A. Moore, Lynn E. Sullivan, William C. Becker, Michael V. Pantalon, Marek C. Chawarski, Declan T. Barry, Patrick G. O'Connor, Richard S. Schottenfeld
Year: 2008
Topic(s):
Opioids & Substance Use See topic collection
6835
Long‐acting naltrexone has long‐acting benefits and 100% induction rates are not difficult to achieve
Type: Journal Article
Authors: Colin Brewer, Emmanuel Streel
Year: 2019
Topic(s):
Opioids & Substance Use See topic collection
6836
Longer-term effects of modernized collaborative care for depression on multiple mental health factors (eIMPACT): A randomized controlled trial
Type: Journal Article
Authors: M. K. Williams, A. L. Shell, W. Wu, K. L. MacDonald, C. M. Callahan, J. I. Nurnberger Jr., C. A. Crawford, M. D. Schuiling, J. C. Stewart
Year: 2026
Abstract:

BACKGROUND: Integrating digital mental health into collaborative care could address multiple mental health factors. To determine the longer-term effects of modernized collaborative care for depression on overlapping mental health factors, we analyzed data from the eIMPACT trial. METHODS: Primary care patients with depression and elevated cardiovascular disease risk (N = 216, Mage: 59 years, 78 % female, 50 % Black, 46 % with income <$10,000/year) were randomized to 12 months of the eIMPACT intervention (modernized collaborative care involving internet cognitive-behavioral therapy [iCBT], telephonic CBT, and/or select antidepressants) or usual primary care for depression. Depressive symptoms (Hopkins Symptom Checklist-20 [SCL-20] and Patient Health Questionnaire-9 [PHQ-9]), anxiety symptoms (Generalized Anxiety Disorder-7 [GAD-7]), hostility/anger/aggression (Buss-Perry Aggression Questionnaire [BPAQ]), and trait positive affect (Positive and Negative Affect Schedule-Positive Affect Subscale [PANAS-PA]) were measured at 0, 6, 12, and 24 months. RESULTS: Compared to the usual care group, the intervention group exhibited significant improvements across all outcomes. The intervention group advantage increased over the treatment period, peaked at post-treatment (12 months: SCL-20 d(adj) = -0.57, PHQ-9 d(adj) = -0.63, GAD-7 d(adj) = -0.50, BPAQ d(adj) = -0.17, PANAS-PA d(adj) = 0.41), and decreased over the follow-up period (24 months: SCL-20 d(adj) = -0.24, PHQ-9 d(adj) = -0.29, GAD-7 d(adj) = -0.20, BPAQ d(adj) = 0.06, PANAS-PA d(adj) = 0.17). CONCLUSIONS: Modernized collaborative care improved multiple mental health factors, highlighting the feasibility and longer-term benefits of blending collaborative care and digital mental health across racial, education, and income groups. Future implementation of such interventions could promote equitable access to high-quality care. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02458690.

Topic(s):
HIT & Telehealth See topic collection
6839
Longitudinal changes in self-efficacy, mental health, abuse, and stages of change, for women fearful of a partner: Findings from a primary care trial (WEAVE)
Type: Journal Article
Authors: Sonia A. Reisenhofer, Kelsey Hegarty, Jodie Valpied, Lyndsey F. Watson, Mary-Ann Davey, Angela Taft
Year: 2019
Topic(s):
Healthcare Disparities See topic collection
6840
Longitudinal cohort studies of addiction treatment initiation and opioid overdose prevention efforts in North Carolina
Type: Web Resource
Authors: Apostolos Alexander Alexandridis
Year: 2019
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.